INTRATAB LABS INC.

 

 

                                                THERAPIES WHEN TIME MATTERS ™

News and Events





2017 Conference Presentations


July 12-14, 2017

IntraTab Labs presents at INTERNATIONAL SYMPOSIUM OF DRUG DELIVERY SYSTEMS (SDDS 2017), Prague, Czech Republic 

http://www.bitcongress.com/SDDS2017


2016 Conference Presentations


November 16-17, 2016

IntraTab Labs presents at 3RD ANNUAL NEXT GENERATION IN NICOTINE DELIVERY CONFERENCE, London, UK 


October 27-28, 2016

IntraTab Labs presents at PODD-PARTNERSHIPS IN DRUG DELIVERY Conference Fairmont Copley Plaza, Boston, MA     

http://PODD   PODD LinkedIn





2016 Patent Portfolio Summary


Forty-three (43) Patents Issued Worldwide (October 2016)


Numerous Patent Applications Pending

Patents Granted in 2016

USA (4 PATENTS),  CANADA , EUROPEAN UNION, SWITZERLAND, GERMANY, SPAIN, FRANCE, GREAT BRITAIN, IRELAND, ITALY, INDIA, ISRAEL

 




2015 YEAR IN REVIEW

Product Launches, Patents Granted & Conference Presentations


October 2015


IntraTab Pharmaceutical Formulation Industry Conference Presentation

IntraTab Labs presents at AAPS - ANNUAL MEETING OF AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS

Orlando, FL


IntraTab Pharmaceutical Industry Conference Presentation

IntraTab Labs presents at PODD-PARTNERSHIPS IN DRUG DELIVERY CONFERENCE 2015

Boston, MA



September 2015


Melatonin Product Launch- Hy-Vee ® Stores
Melatonin 5mg tablets using the IntraTab Labs patented sublingual technology is commercially launched as a Hy-Vee branded product in the USA

IntraTab Tobacco Industry Conference Presentation
IntraTab Labs presents its sublingual delivery technology for Nicotine at the 69th TSRC Annual Tobacco and Science Research Conference in Naples, FL

 


May 2015


Melatonin Product Launch- Kroger ® Chain of Stores

Melatonin 5 mg tablets using the IntraTab Labs patented sublingual technology is commercially launched as a Kroger branded product in the USA.



IntraTab announces first ever sales of a product ulilizing IntraTab's patented sublingual drug delivery technology.

PL Developments has commercialized and sold 5 mg Melatonin Sublingual Tablets under a license agreement with IntraTab Labs established in 2014.



NicoFi™ IntraTab's 1 mg Nicotine Tablet launches in the USA

NicoFi™ is commercially launched in the USA by IntraTab Labs' licensee PL Developments.  This represents the launch of the first nicotine product utilizing IntraTab Lab's proprietary sublingual delivery technology. 



Patent Granted in China

China issues IntraTab Labs Patent for Sublingual Delivery of hormones.



March 2015


IntraTab Tobacco Industry Conference Presentation

IntraTab Labs presents at GFN-GLOBAL FORUM ON NICOTINE

Warsaw, Poland 

 

January 2015


Patents Granted in USA

USPTO issues IntraTab Labs Two (2) Patents for its sublingual delivery technology for nicotine and hormones in the USA. 



2014 YEAR IN REVIEW


September 2014


IntraTab Announces new CEO

Rudy Emmelot joins IntraTab Labs as CEO

June 2014


Patent Granted in Japan

Japan issues Patent to IntraTab Labs for sublingual delivery technology hormone patent.


Patents Granted in Australia

Australia issues Patent to IntraTab Labs for sublingual delivery technology hormone patent.



May 2014


IntraTab Announces new Scientific Advisor

Jay Sisco PhD joins IntraTab Labs as Scientific Advisor



January 2014


Patents Granted in Japan

Japan issues Patent to IntraTab Labs for sublingual delivery technology platform.



2013 YEAR IN REVIEW

 

October 2013


Patents Granted in Indonesia

Indonesia issues Patent to IntraTab Labs for its sublingual delivery technology platform.

 

August 2013


IntraTab enters into First Ever Product Evaluation Agreement

IntraTab signs Product Evaluation Agreement for Development of Two (2) Molecules for FDA 505(b)(2) Regulatory Pathway.



April 2013


Patents Granted in European Union

European Union issues Patent to IntraTab Labs for its sublingual delivery technology platform.

 

March 2013


IntraTab Enters into First Ever Product Development & License Agreement

PL Devleopments (PLD) and IntraTab Labs have entered into an exclusive licensing agreement whereby PLD will manufacture and commercialize two products utilizing ILI’s novel and patented IntraTab™ technology for the North American Market - Nicotine and Melatonin

 


Patents Granted in Russian Federation

Russian Federation issues IntraTab Labs a patent for its sublingual delivery technology - estradiol, testosterone and melatonin.



2012 YEAR IN REVIEW

 

August 2012


IntraTab Labs awarded STTR Grant from NIH/NIDA

IntraTab Labs was awarded an STTR Grant by the National Institute of Health through the National Institute on Drug Abuse for a Pilot Pharmacokinetic Study on IntraTab's novel sublingual delivery technology for a nicotine product.
 

July 2012


Patent Granted in South Korea

South Korea issues Patent to IntraTab Labs for sublingual delivery technology

 

April 2012


Patents Granted in China

China issues Patent to IntraTab Labs for sublingual delivery technology